Prestige Consumer Healthcare (PBH) Accumulated Expenses (2011 - 2025)
Prestige Consumer Healthcare (PBH) recorded quarterly Accumulated Expenses of $15.1 million in Q4 2025, down 77.98% quarter-over-quarter from $68.5 million in Q3 2025, and down 75.25% on a YoY basis from $60.9 million in Q4 2024.
Prestige Consumer Healthcare (PBH) Accumulated Expenses (2011 - 2025) Analysis & Trends
Prestige Consumer Healthcare's Accumulated Expenses history runs 15 years deep, the most recent figure standing at $15.1 million for Q4 2025.
- In Q4 2025, Accumulated Expenses fell 75.25% year-over-year to $15.1 million; the TTM figure through Dec 2025 stood at $15.1 million (down 75.25% YoY), while the FY2025 annual figure was $63.5 million, up 13.01% from the prior year.
- Accumulated Expenses was $15.1 million for Q4 2025 at Prestige Consumer Healthcare, down from $68.5 million in the prior quarter.
- In the past five years, Accumulated Expenses ranged from a high of $78.6 million in Q3 2021 to a low of $15.1 million in Q4 2025.
- Historically, Accumulated Expenses has averaged $50.0 million across 5 years, with a median of $60.5 million in 2023.
- The sharpest annual moves came in 2021 and 2022: Accumulated Expenses soared 946.57% in 2021, then tumbled 80.05% in 2022.
- A 5-year view of Accumulated Expenses shows it stood at $71.0 million in 2021, then retreated by 0.01% to $71.0 million in 2022, then decreased by 8.34% to $65.1 million in 2023, then retreated by 6.38% to $60.9 million in 2024, then slumped by 75.25% to $15.1 million in 2025.
- The last three Accumulated Expenses figures came in at $15.1 million (Q4 2025), $68.5 million (Q3 2025), and $63.8 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Prestige Consumer Healthcare | 2.37 Bn | 2.31 Bn | 157.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 15.08 Mn |
| Sep 30, 2025 | 68.48 Mn |
| Jun 30, 2025 | 63.78 Mn |
| Mar 31, 2025 | 63.46 Mn |
| Dec 31, 2024 | 60.92 Mn |
| Sep 30, 2024 | 57.38 Mn |
| Jun 30, 2024 | 54.86 Mn |
| Mar 31, 2024 | 56.15 Mn |
| Dec 31, 2023 | 65.06 Mn |
| Sep 30, 2023 | 60.08 Mn |
| Jun 30, 2023 | 15.19 Mn |
| Mar 31, 2023 | 15.69 Mn |
| Dec 31, 2022 | 70.98 Mn |
| Sep 30, 2022 | 15.69 Mn |
| Jun 30, 2022 | 15.18 Mn |
| Mar 31, 2022 | 74.11 Mn |
| Dec 31, 2021 | 70.99 Mn |
| Sep 30, 2021 | 78.65 Mn |
| Jun 30, 2021 | 17.07 Mn |
| Mar 31, 2021 | 61.40 Mn |